Trial · NCT07905326
Muscle Architecture, Stiffness, and Neuromuscular Activation in Unilateral Adhesive Capsulitis
NCT07905326, Completed, Ankara Yildirim Beyazıt University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Muscle Architecture, Stiffness, and Neuromuscular Activation in Unilateral Adhesive Capsulitis. Trials, record NCT07905326. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07905326
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Muscle Architecture, Stiffness, and Neuromuscular Activation in Unilateral Adhesive Capsulitis
- NCT number
- NCT07905326
- Status
- Completed
- Enrollment
- 32 participants, actual
- Lead sponsor
- Ankara Yildirim Beyazıt University
- Conditions
- Adhesive Capsulitis of the Shoulder
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Side-to-Side Difference in Muscle Thickness | Baseline (single assessment at the initial study visit) | Ultrasound muscle thickness (cm) in the supraspinatus, infraspinatus, teres minor, and anterior, middle, and posterior deltoid; compare the affected shoulder with the asymptomatic contralateral shoulder. |
| Primary | Side-to-Side Difference in Fascicle Length | Baseline (single assessment at the initial study visit) | Ultrasound fascicle length (cm) in the supraspinatus, infraspinatus, teres minor, and anterior, middle, and posterior deltoid; compare the affected shoulder with the asymptomatic contralateral shoulder. |
| Primary | Side-to-Side Difference in Physiological Cross-Sectional Area | Baseline (single assessment at the initial study visit) | Ultrasound-derived physiological cross-sectional area (PCSA; cm²) for the supraspinatus, infraspinatus, teres minor, and deltoid subregions; compare the affected shoulder with the contralateral shoulder. |
| Primary | Side-to-Side Difference in Pennation Angle | Baseline (single assessment at the initial study visit) | Ultrasound pennation angle (degrees) for the supraspinatus, infraspinatus, teres minor, and deltoid subregions; compare the affected shoulder with the contralateral shoulder. |
| Primary | Side-to-Side Difference in Shear-Wave Elastography Stiffness | Baseline (single assessment at the initial study visit) | Mean Young's modulus (kPa) from three acquisitions for each muscle; compare the affected shoulder with the asymptomatic contralateral shoulder. |
| Primary | Side-to-Side Difference in Normalized Surface EMG Activation | Baseline (single assessment at the initial study visit) | Mean root-mean-square amplitude during dumbbell scaption, normalized to maximal voluntary isometric contraction (%MVIC), for the supraspinatus, infraspinatus, teres minor, and deltoid subregions; compare the affected shoulder with the contralateral shoulder. |
| Secondary | Difference in Affected-Side Muscle Parameters Between Disease Phases | Baseline (single assessment at the initial study visit) | Compare affected-side muscle architecture, shear-wave elastography stiffness, and normalized EMG parameters between the freezing phase (VAS 6-10; n=15) and frozen phase (VAS 0-5; n=17). |
| Secondary | Association Between Affected-Side Muscle Parameters and Shoulder Function | Baseline (single assessment at the initial study visit) | Assess correlations between affected-side muscle architecture, shear-wave elastography stiffness, normalized EMG, and the Constant-Murley Score, UCLA Shoulder Scale, ASES, DASH, QuickDASH, and Oxford Shoulder Score. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07905326
GET https://conductscience.org/api/trials/v1/NCT07905326/registered